ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

N4P N4 Pharma Plc

0.775
-0.05 (-6.06%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -6.06% 0.775 0.75 0.80 0.825 0.775 0.83 611,345 15:32:48
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.35 1.39M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.83p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.175p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.39 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.35.

N4 Pharma Share Discussion Threads

Showing 3176 to 3198 of 8600 messages
Chat Pages: Latest  128  127  126  125  124  123  122  121  120  119  118  117  Older
DateSubjectAuthorDiscuss
23/4/2018
13:53
Double bottom and a nice reversal lovely jubbly
jakleeds
20/4/2018
15:14
You lads get far too excited about a 1.7% rise..
dplewis1
20/4/2018
12:44
N I C E !!!!
escapetohome
20/4/2018
08:47
Hitting base, this should be up over 30p:)
ch1rp
19/4/2018
13:31
Yes I think there is little doubt it works as a drug. And as per the RNS the trials are also about measuring the concentration in blood over a period of time for fed and fasted. This is key scientific data required for regulatory discussions pre phase 3 as well as showing to potential partners it is really effective.
toadhall1
19/4/2018
13:15
Maybe Jak, but they are not going to say officially ;-)A new drug has around a 4% chance of making it to market. A reformulation around 80-90% IIRC?
tp6
19/4/2018
11:14
Surely some of the directors/employees will have tried it and know if it works ??
jakleeds
19/4/2018
08:51
Not a chance im selling at 20 p.

This will be higher if trials successful.

escapetohome
19/4/2018
08:49
@flashheart ..Lol indeed. "I present to you a buying opportunity.."
dplewis1
18/4/2018
21:02
hTTps://uk.webfg.com/news/aim-bulletin/n4-pharma-firms-up-details-for-erectile-dysfunction-drug-trial--3247877.html
parob
18/4/2018
14:10
N4 on twitter:Delighted to be shortlisted as a finalist in the start up category for the @medilinkem Business Awards #n4pIt's like waiting for a bus... #nuvec also shortlisted as a finalist for the @MedilinkEM Business Awards in the Innovation category #n4p
parob
18/4/2018
09:37
Nothing a sure thing on AIM, but good to see they are progressing well and there appears to be a good chance of success, he solution is simple but the manufacture for testing will need to be spot on.
urigem
18/4/2018
08:38
Ok thanks for the responses. As far as clinical trials go I don't suppose they were too short of applicants. I wonder if they give them any assistance in getting it to wear off or if there are a dozen blokes walking round Derby knocking holes in cheap doors?
dplewis1
18/4/2018
08:36
Yes, these are not complex mechanisms of action, so I would not expect poor results. These actions are used for other drugs, albeit not together. The beauty with N4s version is it's complex simplicity, pure genius
trotterstrading
18/4/2018
08:31
Don’t want to speculate but my guess is that they are confident it works. The question is whether or not it needs tweaking before it comes to market:

The data gathered from the Trial will enable the Company to establish whether its reformulation has been sufficiently successful to allow N4 Pharma to prepare for a pre-IND meeting with the FDA towards the end of this year or whether further amendments to the reformulation may be required to optimise efficacy.

jakleeds
18/4/2018
08:27
All we need now is some good Nuvec news and we will be on to new highs.
parob
18/4/2018
08:17
From John on lse :

The tab has a soluble outer coating (quick release component) which dissolves in the mouth before swallowing the inner core for the slow release. Nov prezzo gives full details.

jakleeds
18/4/2018
08:17
N4's sildenafil has outer and inner coating as far as I'm aware
parob
18/4/2018
08:16
Can someone with a better knowledge of clinical trials explain to me why they compare 100mg of Sildenafil against 50mg of viagra? Not a loaded question before anyone gets all uppity, just want to understand how the trial will be performed.
dplewis1
18/4/2018
08:12
In the meantime, the market had reacted positively to this morning’s statement.

Lovely stuff

jakleeds
18/4/2018
08:11
Haha. I’m not pretending anything Jim.

I posted the info that was available late at that time, as I did again this morning.

jakleeds
18/4/2018
08:03
Jak, it was you on the 27th March who posted this..

"The Pilot Trial is due to take place in early 2018 with results expected by the end of April 2018."

So don't pretend you knew any different.

jimbobaroony
18/4/2018
07:57
Exactly Urigem.

And let’s not forget , Nuvec updates could come at any time ...

jakleeds
Chat Pages: Latest  128  127  126  125  124  123  122  121  120  119  118  117  Older

Your Recent History

Delayed Upgrade Clock